1 / 4

Daubert v. Merrell Dow- Pharmaceuticals

Daubert v. Merrell Dow- Pharmaceuticals. By: Monica Valadez & Catherine Lopez. Case Background. Plaintiffs: Daubert (and other minors) Defendants: Merrell Dow Pharmaceuticals, Inc.

chace
Download Presentation

Daubert v. Merrell Dow- Pharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Daubert v. Merrell Dow- Pharmaceuticals By: Monica Valadez & Catherine Lopez

  2. Case Background Plaintiffs: Daubert (and other minors) Defendants: Merrell Dow Pharmaceuticals, Inc. Summary: The plaintiffs were claiming that their defects were caused by the drug the Defendant gave out to their mothers during pregnancy. Verdict: Both sides had valid evidence against one another until it was revealed that the plaintiffs evidence was not accepted to the general scientific community due, therefore the defendants won.

  3. Federal Rule of Evidence 702 (Rule 702) This case contributed to the field of forensics by making the standard for admitting expert testimony in federal courts. By expert testimony they mean that, i. Whether the theory is generally accepted in the scientific community;ii. Whether the theory/method has been subjected to peer review and publication;iii. Whether the theory/method has been tested or can be tested;iv. Whether the potential or known rate of error is acceptable.

  4. Bibliography Bloomberg Law. (1993). Daubert v. Merrell Dow Pharmaceuticals, Inc. Retrieved September 4, 2012, from http://www.bloomberglaw.com/document/X2N776?jcsearch=509%2520U.S.%2520579#jcite&ORIGINATION_CODE=00344

More Related